| 
 Category:cosmetic agents 
  
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information: 
  
Physical Properties: 
| Assay: |  95.00 to 100.00 
 |  
| Food Chemicals Codex Listed:  | No |  
| Boiling Point: |  641.65 °C. @  760.00 mm Hg (est)
 |  
| Flash Point: |  673.00 °F. TCC (  355.90 °C. ) (est)
 |  
| logP (o/w): |   4.321 (est) |  
| Soluble in: |  
|   | water, 0.9738 mg/L @ 25 °C (est) |  
 
  
Organoleptic Properties: 
| Odor and/or flavor descriptions from others (if found). |  
 
  
Cosmetic Information: 
  
Suppliers: 
  
Safety Information: 
|   |  
| Hazards identification |  
|   |  
|  Classification of the substance or mixture |  
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |  
| None found. |  
|  GHS Label elements, including precautionary statements |  
|   |  
| Pictogram |  |  
|   |  
                                                                     
| Hazard statement(s) |  
| None found. |  
| Precautionary statement(s) |  
| None found. |  
| Oral/Parenteral Toxicity:  |  
| 
Not determined
 |  
| Dermal Toxicity:  |  
| 
Not determined
 |  
| Inhalation Toxicity:  |  
| 
Not determined
 |  
 
  
Safety in Use Information: 
| Category:  |  | cosmetic agents |  
| Recommendation for madecassic acid usage levels up to:  |  |   | not for fragrance use.
 |  
|   |  
| Recommendation for madecassic acid flavor usage levels up to:  |  
|   | not for flavor use.
 |  
 
  
Safety References: 
| EPI System: View |  
| AIDS Citations:Search |  
| Cancer Citations:Search |  
| Toxicology Citations:Search |  
| EPA ACToR:Toxicology Data |  
| EPA Substance Registry Services (SRS):Registry |  
| Laboratory Chemical Safety Summary :73412 |  
| National Institute of Allergy and Infectious Diseases:Data |  
| (1S,2R,4aS,6aR,6aS,6bR,8R,8aR,9R,10R,11R,12aR,14bS)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |  
| Chemidplus:0018449417 |  
 
  
References: 
|   | (1S,2R,4aS,6aR,6aS,6bR,8R,8aR,9R,10R,11R,12aR,14bS)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |  
| NIST Chemistry WebBook: | Search Inchi |  
| Pubchem (cid): | 73412 |  
| Pubchem (sid): | 135033173 |  
 
  
Other Information: 
  
Potential Blenders and core components  note 
  
Potential Uses: 
  
Occurrence (nature, food, other): note 
  
Synonyms: 
|   | brahmic acid |  | (1S,2R,4aS,6aR,6aS,6bR,8R,8aR,9R,10R,11R,12aR,14bS)-8,10,11- | trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid |  |   | urs-12-en-28-oic acid, 2,3,6,23-tetrahydroxy-, (2a,3b,4a,6b)- |  
 
  
Articles:
| PubMed:Metabolomic analysis of methyl jasmonate-induced triterpenoid production in the medicinal herb Centella asiatica (L.) urban. |  
| PubMed:[Studies on fingerprints of Centella asiatica by HPLC]. |  
| PubMed:Two new triterpene glycosides from Centella asiatica. |  
| PubMed:Madecassic acid inhibits the mouse colon cancer growth by inducing apoptosis and immunomodulation. |  
| PubMed:Asiaticoside, a component of Centella asiatica, inhibits melanogenesis in B16F10 mouse melanoma. |  
| PubMed:Centella asiatica in dermatology: an overview. |  
| PubMed:Metabolomic analysis of methyl jasmonate-induced triterpenoid production in the medicinal herb Centella asiatica (L.) urban. |  
| PubMed:[Simultaneous determination of madecassoside,asiaticoside and their aglycones in Centella asiatica (L.) urban extracts by RP-HPLC]. |  
| PubMed:Identification of Major Active Ingredients Responsible for Burn Wound Healing of Centella asiatica Herbs. |  
| PubMed:Factors affecting the content of pentacyclic triterpenes in Centella asiatica raw materials. |  
| PubMed:Titrated extract of Centella asiatica provides a UVB protective effect by altering microRNA expression profiles in human dermal fibroblasts. |  
| PubMed:Centella asiatica attenuates the neurobehavioral, neurochemical and histological changes in transient focal middle cerebral artery occlusion rats. |  
| PubMed:Bioavailability, distribution, and antioxidative effects of selected triterpenes in mice. |  
| PubMed:[Studies on fingerprints of Centella asiatica by HPLC]. |  
| PubMed:Triterpene composition and bioactivities of Centella asiatica. |  
| PubMed:Two new triterpene glycosides from Centella asiatica. |  
| PubMed:Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) Urban. |  
| PubMed:Conversion of alpha-amyrin into centellosides by plant cell cultures of Centella asiatica. |  
| PubMed:Anti-inflammatory effects of madecassic acid via the suppression of NF-kappaB pathway in LPS-induced RAW 264.7 macrophage cells. |  
| PubMed:An improved HPLC-UV method for the simultaneous quantification of triterpenic glycosides and aglycones in leaves of Centella asiatica (L.) Urb (APIACEAE). |  
| PubMed:Triterpenoid saponin content and the expression level of some related genes in calli of Centella asiatica. |  
| PubMed:Association (micellization) and partitioning of aglycon triterpenoids. |  
| PubMed:Incorporation of triterpenic derivatives within an o/w/o multiple emulsion: structure and release studies. |  
| PubMed:Molecular dynamics simulation and thermodynamic modeling of the self-assembly of the triterpenoids asiatic acid and madecassic acid in aqueous solution. |  
| PubMed:[Separation and determination of madecassic acid in triterpenic genins of Centella asiatica by high performance liquid chromatography using beta-cyclodextrin as mobile phase additive]. |  
| PubMed:Identification of triterpenoid compounds of Centella asiatica by thin-layer chromatography and mass spectrometry. |  
| PubMed:Advanced formulation and pharmacological activity of hydrogel of the titrated extract of C. asiatica. |  
| PubMed:Gene expression changes in the human fibroblast induced by Centella asiatica triterpenoids. |  
| PubMed:An improved HPLC method for quantitative determination of six triterpenes in Centella asiatica extracts and commercial products. |  
| PubMed:Medicinal foodstuffs. XXVII. Saponin constituents of gotu kola (2): structures of new ursane- and oleanane-type triterpene oligoglycosides, centellasaponins B, C, and D, from Centella asiatica cultivated in Sri Lanka. |  
| PubMed:New innovations in scar management. |  
| PubMed:Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. |  
| PubMed:Triterpenes from Centella asiatica stimulate extracellular matrix accumulation in rat experimental wounds. |  
| PubMed:Quantitative determination of triterpenes in extracts and phytopreparations of Centella asiatica (L.) urban. |  
| PubMed:Influence of asiatic acid, madecassic acid, and asiaticoside on human collagen I synthesis. |  
| PubMed:Centella asiatica (Indian pennywort), an effective therapeutic but a weak sensitizer. |  
| PubMed:Stimulation of collagen synthesis in fibroblast cultures by a triterpene extracted from Centella asiatica. |  
| PubMed:Contact dermatitis due to madecassol. |  
| PubMed:The metabolism of asiatic acid,-madecassic acid and asiaticoside in the rat. |  
 
  
 |